Clinical guidelines for screening of liver cirrhosis complications remain, and clinical judgement must prevail

Affiliations

¹ Department of Medicine, Division of Infectious Diseases and Global Public Health, UC San Diego, San Diego, California.
² National Institute of Allergy and Infectious Diseases. Bethesda, Maryland, USA.

Editorial

Edward R Cachay et al. AIDS. 2021.

. 2021 Nov 1;35(13):2211-2213.

doi: 10.1097/QAD.0000000000003022.

¹ Department of Medicine, Division of Infectious Diseases and Global Public Health, UC San Diego, San Diego, California.
² National Institute of Allergy and Infectious Diseases. Bethesda, Maryland, USA.

No abstract available

Comment on

Kinetics of emergence of liver complications in hepatitis C virus infected patients and advanced fibrosis, with and without HIV-coinfection, after sustained virological response.
Corma-Gómez A, Macías J, Téllez F, Morano L, Rivero A, Serrano M, Ríos MJ, Vera-Méndez FJ, Santos M, Real LM, Palacios R, Santos IL, Geijo P, Imaz A, Merino D, Galindo MJ, Reus-Bañuls S, López-Ruz MÁ, Galera C, Pineda JA; RIS-HEP13 and GEHEP 011 study groups. Corma-Gómez A, et al. AIDS. 2021 Nov 1;35(13):2119-2127. doi: 10.1097/QAD.0000000000002959. AIDS. 2021. PMID: 34049354

1. Kobayashi M, Ikeda K, Hosaka T, et al. Natural history of compensated cirrhosis in the Child-Pugh class A compared between 490 patients with hepatitis C and 167 with B virus infections. J Med Virol. 2006;78:459–65 - PubMed
1. Toshikuni N, Izumi A, Nishino K, et al. Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus-related cirrhosis. J Gastroenterol Hepatol. 2009;24:1276–83 - PubMed
1. Janjua NZ, Wong S, Abdia Y et al. Impact of direct-acting antivirals for HCV on mortality in a large population-based cohort study. J Hepatol. 2021. June 4. Epub ahead of print. - PubMed
1. Carrat F, Fontaine H, Dorival C, et al. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. Lancet 2019; 393:1453–1464 - PubMed
1. Sahakyan Y, Lee-Kim V, Bremner KE, Bielecki JM, Krahn MD. Impact of direct-acting antiviral regimens on mortality and morbidity outcomes in patients with chronic hepatitis c: Systematic review and meta-analysis. J Viral Hepat. 2021;28:739–754 - PubMed